Literature DB >> 19816990

Appearance of electrocardiographic initial U-wave inversion dependent on pressure-induced early diastolic impairment in patients with hypertension.

Kunihisa Miwa1.   

Abstract

BACKGROUND: ECG U-wave inversion can be classified as initial and terminal U inversion according to the phasic relationship to positive U-wave deflection. Initial U inversion is occasionally observed in hypertensive patients while terminal U inversion frequently appears during severe myocardial ischemia. HYPOTHESIS: The genesis of initial U inversion may be related to pressure-induced diastolic dysfunction.
METHODS: In order to clarify the genesis of initial U-wave inversion we studied 11 consecutive hypertensive patients with both initial U inversion and impaired left ventricular early relaxation who were evaluated using Doppler echocardiography.
RESULTS: The U inversion disappeared during acute pressure lowering by sublingual administration of nitroglycerin. The U inversion also disappeared and relaxation improved significantly after chronic blood pressure lowering. Initial U inversion reappeared during a cold pressor test.
CONCLUSION: The appearance of initial U inversion was dependent on the pressure-induced impaired left ventricular early relaxation in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816990      PMCID: PMC6653214          DOI: 10.1002/clc.20487

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  The Double U Wave-Should the Electrocardiogram be Interpreted Echocardiographically?

Authors:  James Ker
Journal:  Clin Med Insights Cardiol       Date:  2010-09-07

2.  Electrocardiographic Features of Left Ventricular Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Systematic Review.

Authors:  Anne-Mar Van Ommen; Elise Laura Kessler; Gideon Valstar; N Charlotte Onland-Moret; Maarten Jan Cramer; Frans Rutten; Ruben Coronel; Hester Den Ruijter
Journal:  Front Cardiovasc Med       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.